CRSA PARIS

What CRSA PARIS does

CRSA (Centre de Recherche scientifique Saint-Antoine) is a French public biomedical research institution operating as UMR_S 938, jointly labeled by INSERM (Institut national de la santé et de la recherche médicale) and Sorbonne Université. Headquartered at Hôpital Saint-Antoine in Paris, the center conducts fundamental and translational research across two principal scientific themes: oncology/hematology and metabolism/inflammation. Research is performed in direct collaboration with the clinical and biological services of three AP-HP (Assistance Publique – Hôpitaux de Paris) hospitals—Saint-Antoine, Tenon, and Armand Trousseau—enabling bench-to-bedside translation within a single hospital group.

The center is organized into 12 INSERM- and Sorbonne Université-labeled research teams plus one administrative team, supported by approximately 400 researchers, clinicians, students, and administrative staff. CRSA operates five shared technical platforms: PHEA (preclinical development with L2/L3 animal facilities), CISA Cytométrie (flow cytometry), CISA Imagerie (microscopy and cell imaging), Spectrométrie de masse (mass spectrometry, lipidomics, and proteomics), and Histomorphologie. These platforms underpin both internal team research and external collaborative work.

As a public nonprofit research unit, CRSA does not commercialize products or services and has no commercial pricing. Revenue consists of institutional allocations from INSERM, Sorbonne Université, and AP-HP. The UMR_S 938 designation was renewed for a four-year term (January 2025 – December 2029). Outreach and dissemination occur through scientific publications, recurring seminars (Les Lundis de Saint-Antoine, Séminaire Annuel), and public engagement events such as the Fête de la Science.

Name

CRSA PARIS

Legal name

CRSA - Centre De Recherche scientifique Saint-Antoine (INSERM - UMR_S 938)

Website

https://crsa.fr

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

CRSA is a French public biomedical research center (UMR_S 938) jointly run by INSERM and Sorbonne Université, conducting fundamental and translational research in oncology/hematology and metabolism/inflammation across 12 research teams and five shared technical platforms serving the Saint-Antoine, Tenon, and Armand Trousseau hospitals.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAGAAAE

Central Laboratory & Clinical Trial Testing CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAB

Preclinical CROs (Discovery/Pharmacology/DMPK)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAL

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

Keywords

• Biomedical research
• Translational research
• Preclinical development
• Mass spectrometry services
• Flow cytometry analysis

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

CRSA is a public biomedical research center (UMR_S 938) that conducts fundamental, translational, preclinical, and clinical research in oncology/hematology and metabolism/inflammation. It operates five shared technical platforms — PHEA preclinical development, CISA Cytométrie, CISA Imagerie, mass spectrometry, and Histomorphologie — providing specialized research infrastructure and services to its 12 research teams and affiliated clinical collaborators at AP-HP hospitals.

Product overview

CRSA (Centre de Recherche scientifique Saint-Antoine) is a biomedical research center affiliated with INSERM and Sorbonne Université, organized as UMRS 938. The center operates as a unified research institution rather than a product company, with 12 labeled research teams and one administrative team. CRSA provides access to 4 technical platforms: PHEA (preclinical development with animal housing and L2/L3 laboratories), CISA Cytométrie (flow cytometry), CISA Imagerie (imaging), Spectrométrie de masse (mass spectrometry for lipidomics and proteomics), and Histomorphologie (histological studies). Research is conducted in two main thematic areas: oncology/hematology and metabolism/inflammation, spanning fundamental, pathophysiological, preclinical, and clinical levels. The center collaborates with clinical and biological services from Saint-Antoine, Tenon, and Armand Trousseau hospitals.

Differentiator

Problem solved

Functional benefit

Products and services

• Plateforme de développement pré-clinique (PHEA) Preclinical development platform providing animal housing and experimentation services, including L2 and L3 laboratory facilities, for biomedical researchers studying oncology, hematology, metabolism, and inflammation.
• CISA Cytométrie Flow cytometry platform offering cell analysis and sorting services for biomedical research applications.
• CISA Imagerie Imaging platform providing microscopy and cell imaging services for biomedical research.
• Spectrométrie de masse Mass spectrometry platform providing lipidomic and proteomic analysis services for research applications.
• Histomorphologie Histomorphology platform providing tissue analysis and histological studies services, under the scientific responsibility of Dominique Wendum.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• INSERMcoreStrategic or Co-development Partner · 1 January 2025INSERM (Institut national de la santé et de la recherche médicale) is the primary institutional partner, co-labeling the UMR_S 938 research unit and providing core funding. The research unit was renewed for 4 years (January 2025 - December 2029).
• Sorbonne UniversitécoreStrategic or Co-development Partner · 1 January 2025Sorbonne Université co-labels the UMR_S 938 research unit and provides institutional support. The research unit was renewed for 4 years (January 2025 - December 2029).
• AP-HP (Assistance Publique - Hôpitaux de Paris)coreStrategic or Co-development PartnerAP-HP provides the hospital infrastructure and clinical services. Research is conducted in collaboration with clinical and biological services at Saint-Antoine, Tenon, and Armand Trousseau hospitals.
• Institut CarnotcoreStrategic or Co-development PartnerUMR_S938 is a member of Institut Carnot, which provides additional research funding and partnership opportunities.

Scale indicators4 records

Recent moves7 records

Expansion highlights3 records

Direct peers

• Wellcome Sanger Institute: UK-based genomic and biomedical research institute conducting large-scale studies in cancer, immunology, and metabolic disease. Comparable to CRSA in its publicly funded research mission, multi-team structure, and platform-based infrastructure, though focused primarily on genomics versus CRSA's broader biomedical scope.
• Broad Institute: Cambridge, MA-based biomedical and genomic research institute affiliated with MIT and Harvard, conducting large-scale research in cancer, metabolic disease, and infectious disease. Comparable to CRSA in its multi-team structure, disease-focused thematic organization, and integration of genomic/proteomic platforms, though operating at significantly larger scale.
• Centre Léon Bérard: Lyon-based comprehensive cancer center combining research labs with hospital clinical services, structurally similar to CRSA's hospital-integrated model. Comparable in oncology research focus and translational mandate, though based in Lyon rather than Paris and focused exclusively on cancer versus CRSA's dual-theme scope.
• Gustave Roussy Institute: Leading European cancer research and treatment center located in Villejuif (greater Paris), conducting fundamental, translational, and clinical oncology research integrated with hospital care. Directly comparable to CRSA's hospital-embedded research structure and oncology/hematology thematic focus, though with a pure-oncology mandate versus CRSA's dual-theme portfolio.
• Institut Curie: Paris-based biomedical research center combining fundamental cancer research with clinical services at its hospital. Highly comparable to CRSA in its hospital-integrated research model, Paris location, and dual cancer/translational focus, though Curie has a stronger historical emphasis on oncology and radiation therapy.
• Institut Pasteur: Paris-based biomedical research institution conducting fundamental and translational research across infectious disease, immunology, cancer, and developmental biology. Comparable to CRSA in its Paris location, INSERM-adjacent status, multi-team research structure, and breadth of biomedical platforms, though Pasteur has a broader thematic mandate and stronger international brand.

Broad incumbents

• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in life sciences with sites across Europe conducting fundamental research in molecular biology, genomics, and structural biology. Comparable to CRSA in its publicly funded research mission and platform-based infrastructure model, though broader in scope and focused more on discovery than clinical translation.
• INSERM (parent institution): The French National Institute of Health and Medical Research, which directly oversees CRSA as a UMR. As the umbrella organization for all French biomedical research units, INSERM is a peer at the institutional level — comparable in mission, funding structure, and governance, though vastly larger in scale and thematic scope.
• AP-HP (Assistance Publique - Hôpitaux de Paris): The public hospital system that hosts CRSA's clinical research at Saint-Antoine, Tenon, and Armand Trousseau hospitals. Comparable as a Paris-based public health institution with embedded research activity, though vastly larger in scope as the operator of 38 hospitals across Île-de-France.
• Sorbonne Université: Major French research university that co-labels UMR_S 938 with INSERM. Comparable to CRSA through the UMR affiliation, biomedical faculty, and shared research infrastructure, though broader in academic scope spanning humanities, sciences, and engineering beyond CRSA's focused biomedical mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/crsa-paris

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRSA PARIS